Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Author:

Gross Neil D.1ORCID,Miller David M.1ORCID,Khushalani Nikhil I.1,Divi Vasu1,Ruiz Emily S.1,Lipson Evan J.1,Meier Friedegund1,Su Yungpo B.1,Swiecicki Paul L.1,Atlas Jennifer1,Geiger Jessica L.1,Hauschild Axel1,Choe Jennifer H.1,Hughes Brett G.M.1ORCID,Schadendorf Dirk1ORCID,Patel Vishal A.1,Homsi Jade1,Taube Janis M.1,Lim Annette M.1,Ferrarotto Renata1,Kaufman Howard L.1,Seebach Frank1,Lowy Israel1,Yoo Suk-Young1,Mathias Melissa1,Fenech Keilah1,Han Hyunsil1,Fury Matthew G.1,Rischin Danny1

Affiliation:

1. From the Department of Head and Neck Surgery (N.D.G.) and the Department of Thoracic and Head and Neck Medical Oncology (R.F.), M.D. Anderson Cancer Center, Houston, and the Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas (J.H.); the Department of Medicine, Division of Hematology and Oncology (D.M.M.), the Department of Dermatology (D.M.M.), and the Department of Surgery (H.L.K.), Massachusetts General Hospital and Harvard Medical School, and the Department of...

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3